StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Reaction

<< Previous

Bullboard Posts

Next >>

Comment by Bucky86on Mar 15, 2021 12:59pm

120 Views

Post# 32799393

RE:RE:RE:RE:Reaction

Hey CBG remember when tripp said 30 million and 7-10 days away for signing a massive health care provider....ya I do too. Cant fault people for being cautious... szls has barely shown anything substantial still. Yes yes some covid revenue but nothing cancerwise.... nothing! I'm still waiting for that nondisclosure clause you talked about between Tripp and the health care provider to be released finally.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China